These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2549749)

  • 21. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
    Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
    J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogenesis of hyperoxalurias and calcium oxalate calculi in intestinal diseases].
    Müller G; Schütte W; Möller T
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(3):105-12. PubMed ID: 3311705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Calcium excretion in patients with calcium oxalate calculi in acid administration].
    Bothor C; Berg W; Pirlich W
    Urologe A; 1987 May; 26(3):133-6. PubMed ID: 3603899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
    Bushinsky DA; Neumann KJ; Asplin J; Krieger NS
    Kidney Int; 1999 Jan; 55(1):234-43. PubMed ID: 9893132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of intestinal oxalate hyperabsorption in patients with idiopathic recurrent calcium oxalate urinary calculi].
    Berg W; Haerting R; Bothor C; Meinig S; Eschholz A; Schulze HP
    Urologe A; 1990 May; 29(3):148-51. PubMed ID: 2382323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine.
    Scurr DS; Latif AB; Sergeant V; Robertson WG
    Proc Eur Dial Transplant Assoc; 1983; 20():440-4. PubMed ID: 6197713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sex specific factors in recurrent idiopathic calcium urolithiasis].
    Weitbrecht M; Hegemann M; Pfab R; Wieser T
    Urologe A; 1987 May; 26(3):129-32. PubMed ID: 3603898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The urinary excretion of inorganic pyrophosphate by normal subjects and patients with renal calculus.
    Russell RG; Hodgkinson A
    Clin Sci; 1966 Aug; 31(1):51-62. PubMed ID: 4287960
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ; Kinder JM; Asplin JR; Coe BJ; Coe FL
    J Urol; 2002 Jun; 167(6):2372-6. PubMed ID: 11992040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Urinary pyrophosphate level in lithiasis. Results of clinical studies on orthophosphate prevention of recurrent lithiasis].
    Sommer-Tsilenis E; Fenner O; Kallistratos G; Timmermann A
    Munch Med Wochenschr; 1967 Sep; 109(38):1971-4. PubMed ID: 4297845
    [No Abstract]   [Full Text] [Related]  

  • 33. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of crystal growth of hydroxyapatite: a constant composition approach.
    Wilson JW; Werness PG; Smith LH
    J Urol; 1985 Dec; 134(6):1255-8. PubMed ID: 2997488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of urine saturation and inhibitory index in patients with calcium oxalate kidney stone and normals.
    Sun CT; Cao LC; Han KH
    Chin Med J (Engl); 1987 Dec; 100(12):935-9. PubMed ID: 3133165
    [No Abstract]   [Full Text] [Related]  

  • 36. [Classification of staghorn calculus disease of the kidney based on 105 personal cases and a review of the literature].
    Sigel A; Schrott KM; Breun H; Heger D
    Urologe A; 1986 Mar; 25(2):101-8. PubMed ID: 3716038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relation between orthophosphate and pyrophosphate in normal subjects and in patients with urolithiasis.
    Conte A; Roca P; Genestar C; Grases F
    Urol Res; 1989; 17(3):173-5. PubMed ID: 2546315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial crystalluria determination and the risk of recurrence in calcium stone formers.
    Daudon M; Hennequin C; Boujelben G; Lacour B; Jungers P
    Kidney Int; 2005 May; 67(5):1934-43. PubMed ID: 15840041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk indicators of urinary calculus formation: value of oxalate and citrate excretion in comparison with the oxalate tolerance value].
    Hannak D; Burczyk U; Bartelt U; Kattermann R
    Urologe A; 1989 Jan; 28(1):20-4. PubMed ID: 2922896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in rat.
    Sakly R; Bardaoui M; Neffati F; Moussa A; Zakhama A; Najjar MF; Hammami M
    Ann Nutr Metab; 2005; 49(2):132-8. PubMed ID: 15860912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.